Anticuerpos monoclonales | sciencenewsnet.in

Breaking News

These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question

Living with Stage 3 lung cancer in your 80s and 90s

ETRI published Key International Standards for Wearable Healthcare

Study Unveils Balance of AI and Preserving Humanity in Health Care

Press Registration for the ASRS 2024 Annual Scientific Meeting Now Open

A systematic review of three key sugar metabolism proteins, HXK, SnRK1 and TOR, in the regulatory network of plant growth, development and stress

Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards

Potential new worlds rescued by citizens of Earth! Early results of people-powered astronomy project ‘out of this world’

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

BIMM University chooses Figshare to showcase its non-traditional research and creative practitioner outputs

25 Apr, 2024

Tratamiento con combinación de anticuerpos monoclonales disminuye hospitalizaciones en pacientes de alto riesgo que contraen COVID-19

September 7, 2021 sarah JonasResearch Results

Los investigadores de Mayo Clinic informan en un estudio observacional que la combinación de casirivimab e imdevimab evita la necesidad de hospitalizar a los pacientes de alto riesgo cuando sufren una infección leve a moderada de la COVID-19.